KR101144600B1 - 일라프라졸의 결정형 a, b의 제조방법 및 이들 결정형의 변환방법 - Google Patents
일라프라졸의 결정형 a, b의 제조방법 및 이들 결정형의 변환방법 Download PDFInfo
- Publication number
- KR101144600B1 KR101144600B1 KR1020090121209A KR20090121209A KR101144600B1 KR 101144600 B1 KR101144600 B1 KR 101144600B1 KR 1020090121209 A KR1020090121209 A KR 1020090121209A KR 20090121209 A KR20090121209 A KR 20090121209A KR 101144600 B1 KR101144600 B1 KR 101144600B1
- Authority
- KR
- South Korea
- Prior art keywords
- ilaprazole
- acid
- crystalline form
- inorganic salt
- preparing
- Prior art date
Links
- 0 CO/C1=C(\*)/C(/CS(c2nc3cc(-[n]4cccc4)ccc3[n]2)=O)=*/CC/C=C1 Chemical compound CO/C1=C(\*)/C(/CS(c2nc3cc(-[n]4cccc4)ccc3[n]2)=O)=*/CC/C=C1 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Saccharide Compounds (AREA)
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020090121209A KR101144600B1 (ko) | 2009-12-08 | 2009-12-08 | 일라프라졸의 결정형 a, b의 제조방법 및 이들 결정형의 변환방법 |
IN3176DEN2012 IN2012DN03176A (es) | 2009-12-08 | 2010-12-08 | |
BR112012012212A BR112012012212A2 (pt) | 2009-12-08 | 2010-12-08 | processos de preparo de formas cristalinas a e b de ilaprazol e processo para conversão das formas cristalinas |
UAA201207006A UA102787C2 (ru) | 2009-12-08 | 2010-12-08 | Способ приготовления кристаллических форм а и в илапразола и способ преобразования кристаллических форм |
EA201200716A EA019058B1 (ru) | 2009-12-08 | 2010-12-08 | Способ получения кристаллических форм а и в илапразола и способ превращения указанных кристаллических форм |
PCT/KR2010/008767 WO2011071314A2 (en) | 2009-12-08 | 2010-12-08 | Processes for preparing crystalline forms a and b of ilaprazole and process for converting the crystalline forms |
CO12097489A CO6541539A2 (es) | 2009-12-08 | 2012-06-08 | Procesos para preparar las formas cristalinas a y b de ilaprazol y proceso para convertir las formas cristalinas |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020090121209A KR101144600B1 (ko) | 2009-12-08 | 2009-12-08 | 일라프라졸의 결정형 a, b의 제조방법 및 이들 결정형의 변환방법 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20110064545A KR20110064545A (ko) | 2011-06-15 |
KR101144600B1 true KR101144600B1 (ko) | 2012-05-16 |
Family
ID=44146052
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020090121209A KR101144600B1 (ko) | 2009-12-08 | 2009-12-08 | 일라프라졸의 결정형 a, b의 제조방법 및 이들 결정형의 변환방법 |
Country Status (7)
Country | Link |
---|---|
KR (1) | KR101144600B1 (es) |
BR (1) | BR112012012212A2 (es) |
CO (1) | CO6541539A2 (es) |
EA (1) | EA019058B1 (es) |
IN (1) | IN2012DN03176A (es) |
UA (1) | UA102787C2 (es) |
WO (1) | WO2011071314A2 (es) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20190055481A (ko) | 2017-11-15 | 2019-05-23 | 주식회사 다산제약 | 고순도 일라프라졸 결정형 b의 제조방법 |
KR20210019469A (ko) | 2021-02-02 | 2021-02-22 | 주식회사 파마코스텍 | 일라프라졸 나트륨 결정형 및 신규한 제조방법 |
KR102250509B1 (ko) * | 2020-12-09 | 2021-05-11 | 유니셀랩 주식회사 | 새로운 일라프라졸/자일리톨 공결정 |
KR20220065235A (ko) | 2020-11-13 | 2022-05-20 | 주식회사 파마코스텍 | 일라프라졸 혼형 결정의 신규한 제조방법 |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103204842B (zh) * | 2012-01-13 | 2014-10-15 | 丽珠医药集团股份有限公司 | 结晶型艾普拉唑钠水合物及其制备方法 |
CN103204843B (zh) * | 2012-01-13 | 2014-12-31 | 丽珠医药集团股份有限公司 | 结晶型艾普拉唑钠乙醇化物及其制备方法 |
WO2013114232A1 (en) | 2012-02-02 | 2013-08-08 | Lupin Limited | Process for preparation of crystalline form l of ilaprazole |
CN102746277B (zh) * | 2012-06-21 | 2014-05-14 | 丽珠医药集团股份有限公司 | 一种结晶形式的艾普拉唑钠及其制备方法 |
CN102746275B (zh) * | 2012-06-21 | 2014-07-16 | 丽珠医药集团股份有限公司 | 结晶型艾普拉唑钠及其制备方法 |
CN102746276B (zh) * | 2012-06-21 | 2014-07-02 | 丽珠医药集团股份有限公司 | 一种艾普拉唑钠晶型及其制备方法 |
CN105461692A (zh) * | 2014-09-04 | 2016-04-06 | 江苏奥赛康药业股份有限公司 | 艾普拉唑钠化合物及其药物组合物 |
CN107857756B (zh) * | 2017-11-06 | 2022-08-30 | 丽珠医药集团股份有限公司 | 一种艾普拉唑镁晶型及其制备方法 |
CN111187255B (zh) * | 2020-01-13 | 2021-07-20 | 丽珠医药集团股份有限公司 | 右旋艾普拉唑钾盐的制备方法和右旋艾普拉唑的制备方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20090086615A (ko) * | 2006-12-29 | 2009-08-13 | 일양약품주식회사 | 라세믹 일라프라졸의 고체상 형태 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080200515A1 (en) * | 2006-12-29 | 2008-08-21 | Tap Pharmaceutical Products Inc. | Solid state forms of enantiopure ilaprazole |
-
2009
- 2009-12-08 KR KR1020090121209A patent/KR101144600B1/ko active IP Right Grant
-
2010
- 2010-12-08 UA UAA201207006A patent/UA102787C2/ru unknown
- 2010-12-08 BR BR112012012212A patent/BR112012012212A2/pt not_active Application Discontinuation
- 2010-12-08 IN IN3176DEN2012 patent/IN2012DN03176A/en unknown
- 2010-12-08 WO PCT/KR2010/008767 patent/WO2011071314A2/en active Application Filing
- 2010-12-08 EA EA201200716A patent/EA019058B1/ru not_active IP Right Cessation
-
2012
- 2012-06-08 CO CO12097489A patent/CO6541539A2/es unknown
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20090086615A (ko) * | 2006-12-29 | 2009-08-13 | 일양약품주식회사 | 라세믹 일라프라졸의 고체상 형태 |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20190055481A (ko) | 2017-11-15 | 2019-05-23 | 주식회사 다산제약 | 고순도 일라프라졸 결정형 b의 제조방법 |
KR20220065235A (ko) | 2020-11-13 | 2022-05-20 | 주식회사 파마코스텍 | 일라프라졸 혼형 결정의 신규한 제조방법 |
KR102250509B1 (ko) * | 2020-12-09 | 2021-05-11 | 유니셀랩 주식회사 | 새로운 일라프라졸/자일리톨 공결정 |
KR20210019469A (ko) | 2021-02-02 | 2021-02-22 | 주식회사 파마코스텍 | 일라프라졸 나트륨 결정형 및 신규한 제조방법 |
Also Published As
Publication number | Publication date |
---|---|
IN2012DN03176A (es) | 2015-09-25 |
UA102787C2 (ru) | 2013-08-12 |
WO2011071314A2 (en) | 2011-06-16 |
EA019058B1 (ru) | 2013-12-30 |
KR20110064545A (ko) | 2011-06-15 |
EA201200716A1 (ru) | 2012-10-30 |
WO2011071314A3 (en) | 2011-11-10 |
CO6541539A2 (es) | 2012-10-16 |
BR112012012212A2 (pt) | 2015-09-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101144600B1 (ko) | 일라프라졸의 결정형 a, b의 제조방법 및 이들 결정형의 변환방법 | |
KR102417830B1 (ko) | 1-(5-(2,4-다이플루오로페닐)-1-((3-플루오로페닐)술포닐)-4-메톡시-1h-피롤-3-일)-n-메틸메탄아민의 신규한 산부가염 | |
RU2004108953A (ru) | Полиморфные формы рифаксимина, способы их получения и их применение в медицинских препаратах | |
WO2003037881A1 (fr) | Cristal a forme $g(a) ou $g(b) d'un derive acetanilinide | |
KR20200018664A (ko) | 오메캄티브 메카빌의 합성 | |
KR20080064990A (ko) | 세프디니르의 제조방법 | |
US10870654B2 (en) | Pharmaceutically acceptable salts and polymorphic forms of hydrocodone benzoic acid enol ester and processes for making same | |
KR102027388B1 (ko) | 고순도 일라프라졸 결정형 b의 제조방법 | |
KR20190035680A (ko) | 벨리노스테트의 다형태 및 이의 제조 방법 | |
JP5355893B2 (ja) | パントプラゾールナトリウムの製造方法 | |
CN110637009A (zh) | 用于制备4-甲氧基吡咯衍生物的中间体的方法 | |
JP2005521634A (ja) | レパグリニドの製法 | |
KR101032600B1 (ko) | 고순도 레바미피드의 제조방법 | |
KR101316653B1 (ko) | 헤테로고리 화합물의 제조방법 | |
KR101170940B1 (ko) | 결정성 판토프라졸 나트륨 세스퀴수화물의 제조방법 | |
CN107722007B (zh) | 阿哌沙班杂质的制备方法 | |
KR101557702B1 (ko) | 미티글리니드 칼슘 이수화물의 제조방법 | |
EP2643308A1 (en) | Process for the preparation of taurolidine and its intermediates thereof | |
JP3884063B2 (ja) | セフカペンピボキシルのメタンスルホン酸塩 | |
JP2011520873A (ja) | 抗潰瘍薬を合成するための中間体化合物を調製する方法 | |
TWI847144B (zh) | 奧美卡替莫卡必爾的合成 | |
KR100554108B1 (ko) | 에르도스테인의 제조방법 | |
KR100453379B1 (ko) | 피페리딘 유도체의 제조방법 | |
WO2015184797A1 (zh) | N-(2-氯甲基-1-甲基-1h-苯并咪唑-5-酰基)-n-(吡啶-2-基)-3-氨基丙酸乙酯的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20160419 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20170426 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20180427 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20190430 Year of fee payment: 8 |